Table:
begin	end	state
1	30	cytoplasmic
31	52	transmembrane
53	96	non-cytoplasmic
97	115	transmembrane
116	122	cytoplasmic
123	145	transmembrane
146	156	non-cytoplasmic
157	181	transmembrane
182	193	cytoplasmic
194	220	transmembrane
221	231	non-cytoplasmic
232	250	transmembrane
251	264	cytoplasmic
265	284	transmembrane
285	285	non-cytoplasmic
286	314	transmembrane
315	325	cytoplasmic
326	351	transmembrane
352	365	non-cytoplasmic

Input:
>AO356_17390
MTTHTFKPDMPPPSSSIGVVAWMRANMFSSWLNTLLTLFAFYLIYLIVPPLLQWAILDAN
WVGTTRADCTKEGACWVFIQQRFGQFMYGYYPADLRWRVDLTVWAAVLGVAPLFISRFPR
KAIYGLSFLVLYPIIAWCLLHGGVFGLDAVATSQWGGLMLTLVIATVGIVGALPLGIVLA
LGRRSNMPAIRVVCVTFIEFWRGVPLITVLFMSSVMLPLFLPEGMNFDKLLRALIGVILF
QSAYVAEVVRGGLQAIPKGQYEAAAAMGLGYWRSMGLVILPQALKLVIPGIVNTFIALFK
DTSLVIIIGLFDLLNSVKQAAADPKWLGMATEGYVFAALVFWIFCFGMSRYSMHLERKLD
TGHKR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server